19.12.2011 
Josef Penninger

Institute of Molecular Biotechnology (IMBA), Vienna, Austria

“ACE 2-from heart function and SARS infections to amino acid transport”


12.12.2011
Luigi Naldini 

Division of Regenerative Medicine, Stem Cells and Gene Therapy San Raffaele del Monte Tabor Foundation, Milano, Italy

 “Recent advances in hematopoietic stem cell gene therapy: from microRNA regulation to targeted gene transfer” 


05.12.2011
Jan-Michael Peters 

The Research Institute of Molecular Pathology (IMP), Vienna, Austria

 “How cohesin helps to organize and segregate the mammalian genome”


21.11.2011
Günter Weiss 

Division for Clinical Immunology and Infectious Diseases, Department of Internal Medicine, Medical University of Innsbruck, Austria

“Regulatory networks between iron homeostasis, immunity and infection”


14.11.2011
Michael Washburn 

Stowers Institute for Medical Research, Kansas City, Missouri, United States

 “Deletion network analysis for capturing protein complex architecture and elucidating protein function”


07.11.2011 
Stylianos Antonarakis 

Department of Genetic Medicine and Development, University of Geneva Medical School and University Hospitals of Geneva, Switzerland 

“Aneuploidies and chromatin dysregulation”


24.10.2011
Bruce C. Ames 

Children's Hospital Oakland Research Institute (CHORI), United States

“A Diet for Health and Longevity: How Do We Get There?”


10.10.2011 
Ziad Mallat 

Division of Cardiovascular Medicine, University of Cambridge, United Kingdom

“Immuno-modulatory pathways in atherosclerosis”


03.10.2011 
Zhao-Qi Wang

Leibniz Institute for Age Research – Fritz Lipmann Institute, Jena, Germany

“MCPH1 regulates cell division mode of neuroprogenitors via the Chk1-Cdc25-Cdk1 pathway”


26.09.2011 
William Vainchenker 

INSERM U1009 “Hématopoïèse normale et pathologique”, Institut Gustave Roussy, Villejuif France 

“Myeloproliferative neoplasm from JAK2 to TET2”


19.09.2011
Alain Fischer

Université Paris Descartes-Hopital, Necker-Inserm, France 

“Human genetic defects in T cells: some causes and consequences”


05.09.2011 
Roland Schüle 

Department of Urology and Head of Research, Center for Clinical Research, University of Freiburg Medical Center, Germany

“In vivo functions of the histone demethylase LSD1”


06.06.2011 
Emmanouil Dermitzakis 

Department of Genetic Medicine and Development University of Geneva Medical School, Switzerland

“Cellular genomics in human populations”


16.05.2011 
Bhushan Nagar 

Department of Biochemistry, McGill University, Montreal, Canada 

“Structural basis for 5’ nucleotide recognition by Argonaute proteins”


28.03.2011 
Adrian Hill 

University of Oxford and Jenner Institute, United Kingdom 

“Targeting bacterial killers: humans genetics and vaccines”


21.03.2011
Bernhard Horsthemke 

University of Duisburg Essen and Institute of Human Genetics at the University Hospital Essen, Germany “Species-specific differences in genomic imprinting” 


14.03.2011 
Bernhard Küster 

Chair of Proteomics and Bioanalytics, Technische Universität München and Center for Integrated Protein Sciences Munich (CIPSM), Germany

“Quantitative chemical proteomics reveals new drug targets in head and neck cancer” 


07.03.2011 
Blagoy Blagoev

Department of Biochemistry and Molecular Biology, University of Southern Denmark, Denmark 

“Cell signaling and stem cell differentiation: a view from system wide quantitative proteomics”

 

24.01.2011 
Rüdiger Klein 

Max-Planck-Institute of Neurobiology, Martinsried, Germany 

“Molecular mechanisms regulating cell-cell communication by repulsion”


17.01.2011
René Bernards 

Netherlands Cancer Institute, Amsterdam, The Netherlands 

“Uncovering mechanisms of cancer drug resistance through functional genetic screens”